Latest news and press releases about RadNet, Inc. (RDNT): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures.
Price
| Price | $70.57 |
| Market Cap | $5.5B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 4.96 |
| EV / EBITDA | 20.77 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -1.95% |
| Return on Invested Capital | 1.38% |
| Return on Assets | -0.50% |
| Gross Margin | 9.70% |
| Operating Margin | 4.00% |
| Net Margin | -0.93% |
Related companies: BLCO · BRKR · BTSG · CHE · IRTC · KRYS · MMSI
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of RDNT: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks